Logo image of CRVL

CORVEL CORP (CRVL) Stock Fundamental Analysis

NASDAQ:CRVL - Nasdaq - US2210061097 - Common Stock - Currency: USD

88.41  -2.16 (-2.38%)

After market: 88.41 0 (0%)

Fundamental Rating

6

Overall CRVL gets a fundamental rating of 6 out of 10. We evaluated CRVL against 103 industry peers in the Health Care Providers & Services industry. CRVL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRVL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year CRVL was profitable.
In the past year CRVL had a positive cash flow from operations.
In the past 5 years CRVL has always been profitable.
CRVL had a positive operating cash flow in each of the past 5 years.
CRVL Yearly Net Income VS EBIT VS OCF VS FCFCRVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1.2 Ratios

CRVL has a better Return On Assets (17.43%) than 99.03% of its industry peers.
CRVL's Return On Equity of 29.56% is amongst the best of the industry. CRVL outperforms 94.17% of its industry peers.
The Return On Invested Capital of CRVL (28.08%) is better than 96.12% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRVL is significantly above the industry average of 9.38%.
Industry RankSector Rank
ROA 17.43%
ROE 29.56%
ROIC 28.08%
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
CRVL Yearly ROA, ROE, ROICCRVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

CRVL has a Profit Margin of 10.63%. This is amongst the best in the industry. CRVL outperforms 95.15% of its industry peers.
CRVL's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 13.49%, CRVL belongs to the best of the industry, outperforming 84.47% of the companies in the same industry.
CRVL's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 23.44%, CRVL perfoms like the industry average, outperforming 48.54% of the companies in the same industry.
In the last couple of years the Gross Margin of CRVL has grown nicely.
Industry RankSector Rank
OM 13.49%
PM (TTM) 10.63%
GM 23.44%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
CRVL Yearly Profit, Operating, Gross MarginsCRVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.
Compared to 1 year ago, CRVL has about the same amount of shares outstanding.
The number of shares outstanding for CRVL has been reduced compared to 5 years ago.
There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRVL Yearly Shares OutstandingCRVL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRVL Yearly Total Debt VS Total AssetsCRVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 17.57 indicates that CRVL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 17.57, CRVL belongs to the top of the industry, outperforming 97.09% of the companies in the same industry.
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.57
ROIC/WACC3.16
WACC8.88%
CRVL Yearly LT Debt VS Equity VS FCFCRVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.90 indicates that CRVL should not have too much problems paying its short term obligations.
CRVL's Current ratio of 1.90 is fine compared to the rest of the industry. CRVL outperforms 69.90% of its industry peers.
CRVL has a Quick Ratio of 1.90. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
CRVL's Quick ratio of 1.90 is fine compared to the rest of the industry. CRVL outperforms 73.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9
CRVL Yearly Current Assets VS Current LiabilitesCRVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.05%, which is quite impressive.
The Earnings Per Share has been growing by 16.86% on average over the past years. This is quite good.
CRVL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.61%.
CRVL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.62% yearly.
EPS 1Y (TTM)26.05%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%37.38%
Revenue 1Y (TTM)12.61%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%11.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRVL Yearly Revenue VS EstimatesCRVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 48.58 indicates a quite expensive valuation of CRVL.
Compared to the rest of the industry, the Price/Earnings ratio of CRVL is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.93, CRVL is valued quite expensively.
Industry RankSector Rank
PE 48.58
Fwd PE N/A
CRVL Price Earnings VS Forward Price EarningsCRVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CRVL's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRVL.
Industry RankSector Rank
P/FCF 49.67
EV/EBITDA 29.85
CRVL Per share dataCRVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of CRVL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.88
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRVL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORVEL CORP

NASDAQ:CRVL (8/14/2025, 4:30:01 PM)

After market: 88.41 0 (0%)

88.41

-2.16 (-2.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-28 2025-07-28
Earnings (Next)11-03 2025-11-03
Inst Owners53.88%
Inst Owner Change0.47%
Ins Owners7.11%
Ins Owner Change-0.33%
Market Cap4.55B
Analysts0
Price TargetN/A
Short Float %2.75%
Short Ratio5.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 48.58
Fwd PE N/A
P/S 5.08
P/FCF 49.67
P/OCF 35.72
P/B 14.12
P/tB 15.97
EV/EBITDA 29.85
EPS(TTM)1.82
EY2.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY2.01%
OCF(TTM)2.48
OCFY2.8%
SpS17.41
BVpS6.26
TBVpS5.54
PEG (NY)N/A
PEG (5Y)2.88
Profitability
Industry RankSector Rank
ROA 17.43%
ROE 29.56%
ROCE 35.34%
ROIC 28.08%
ROICexc 56.04%
ROICexgc 71.6%
OM 13.49%
PM (TTM) 10.63%
GM 23.44%
FCFM 10.22%
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
ROICexc(3y)48.46%
ROICexc(5y)45.93%
ROICexgc(3y)62.9%
ROICexgc(5y)61.44%
ROCE(3y)35.98%
ROCE(5y)33.03%
ROICexcg growth 3Y4.75%
ROICexcg growth 5Y18.9%
ROICexc growth 3Y6.87%
ROICexc growth 5Y18.29%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
F-Score8
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 121.06%
Cap/Sales 3.99%
Interest Coverage 250
Cash Conversion 84.67%
Profit Quality 96.21%
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z 17.57
F-Score8
WACC8.88%
ROIC/WACC3.16
Cap/Depr(3y)112.41%
Cap/Depr(5y)107.09%
Cap/Sales(3y)3.78%
Cap/Sales(5y)3.81%
Profit Quality(3y)90.78%
Profit Quality(5y)99.01%
High Growth Momentum
Growth
EPS 1Y (TTM)26.05%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%37.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.61%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%11.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.05%
EBIT growth 3Y12.65%
EBIT growth 5Y14.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.81%
FCF growth 3Y34.78%
FCF growth 5Y13.57%
OCF growth 1Y28.29%
OCF growth 3Y23.73%
OCF growth 5Y9.51%